XWELL, Inc. ( XWEL) - Key Metrics
XWEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.90 | -$0.28 | -$0.57 | -$0.59 |
| 2026Q1 | $0.90 | -$1.51 | -$0.62 | -$0.67 |
| 2025Q4 | $2.45 | -$3.18 | -$0.01 | -$0.26 |
| 2025Q3 | $2.64 | -$0.26 | -$0.76 | -$1.10 |
| 2025Q2 | $1.90 | -$0.56 | -$0.59 | -$0.81 |
XWEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1 |
| 2026Q1 | -0.73% | -0.19 |
| 2025Q4 | -2.14% | -0.04 |
| 2025Q3 | -119.06% | -0.95 |
| 2025Q2 | -4.19% | -0.41 |
XWEL
Price: $0.98
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 7.7 million